Quarterly report pursuant to Section 13 or 15(d)

EQUITY (Tables)

v3.8.0.1
EQUITY (Tables)
3 Months Ended
Mar. 31, 2018
Schedule of stock options outstanding

The following table summarizes the shares of the Company’s common stock issuable upon exercise of options outstanding at March 31, 2018:

 

Options Outstanding     Options Exercisable  
Range of
Exercise
Price
    Number
Outstanding at
March 31, 2018
    Range of Weighted Average Remaining Contractual Life
(Years)
    Weighted
Average
Exercise
Price
    Number
Exercisable at
March 31,
2018
    Weighted
Average
Exercise Price
 
$ 0.50       2,000,000       8.87     $ 0.50       777,778     $ 0.50  
  1.49       60,000       4.08       1.49       60,000       1.49  
  1.00       230,000       3.02       1.00       110,000       1.00  
  2.50       120,000       4.76       2.50       30,000       2.50  
$ 0.50–2.50       2,410,000       7.98     $ 0.67       977,778     $ 0.68  
Employee Stock Option [Member]  
Schedule of stock option activities

Employee and director stock option activities for the three months ended March 31, 2018 were as follows:

 

    Number of Options     Weighted Average Exercise Price  
Outstanding at December 31, 2017     2,110,000     $ 0.54  
Granted     120,000       2.50  
Exercised            
Outstanding at March 31, 2018     2,230,000       0.65  
Options exercisable at March 31, 2018     887,778     $ 0.65  
Options expected to vest     1,342,222     $ 0.65  
Schedule of fair value of the options using the Black-Scholes option-pricing model

The fair values of these options granted to employee and director during the three months ended March 31, 2018 were estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions:

 

Dividend rate     0  
Terms (in years)     5.0  
Volatility     185.28 %
Risk-free interest rate     2.25 %
Schedule of non vested stock option activities

A summary of the status of the Company’s nonvested employee and director stock options granted as of March 31, 2018 and changes during the three months ended March 31, 2018 is presented below:

 

      Number of Options     Weighted Average Exercise Price     Grant Date Fair Value  
Nonvested at December 31, 2017       1,428,889     $ 0.51     $ 1,876,079  
Granted       120,000       2.50       289,150  
Vested       (206,667 )     (0.81 )     (315,613 )
Forfeited                    
Nonvested at March 31, 2018       1,342,222     $ 0.65     $ 1,849,616  
Non Employee Stock Option [Member]  
Schedule of stock option activities

Non-employee stock option activities for the three months ended March 31, 2018 were as follows:

 

    Number of Options     Weighted Average Exercise Price  
Outstanding at December 31, 2017     180,000     $ 1.00  
Granted            
Vested     (90,000 )     (1.00 )
Exercised            
Outstanding at March 31, 2018     90,000       1.00  
Options exercisable at March 31, 2018     90,000     $ 1.00  
Options expected to vest     90,000     $ 1.00  
Schedule of fair value of the options using the Black-Scholes option-pricing model

The fair values of these non-employee options vested in the three months ended March 31, 2018 and nonvested non-employee options as of March 31, 2018 were estimated using the Black-Scholes option-pricing model with the following assumptions:

 

Dividend rate     0  
Terms (in years)     3.0  
Volatility     183.23% - 188.29%  
Risk-free interest rate     2.29% - 2.37%  
Schedule of non vested stock option activities

A summary of the status of the Company’s nonvested non-employee stock options granted as of March 31, 2018 and changes during the three months ended March 31, 2018 is presented below:

 

      Number of Options     Weighted Average Exercise Price     Fair Value at
March 31, 2018
 
Nonvested at December 31, 2017       180,000     $ 1.00          
Granted                      
Vested       (90,000 )     (1.00 )        
Forfeited                      
Nonvested at March 31, 2018       90,000     $ 1.00     $ 202,193